Cyterix Pharmaceuticals Receives $9,200,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1e257c37-50dc-409e-a7cc-5565ea7edac0&Preview=1 -
Date
6/8/2011 -
Company Name
Cyterix Pharmaceuticals -
Mailing Address
1300 Seaport Blvd. Redwood City, CA 94063 -
Company Description
The company is developing cytochrome P450- activated drugs. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$9,200,000 -
Transaction Round
Series A -
Proceeds Purposes
Continuing in our cash-efficient business model, we expect these funds to advance our two lead compounds through IND-enabling studies, as well as further expand the development of our technology platform and our exploration of new targets within the extra-hepatic cytochrome P450 enzyme family. -
M&A Terms
-
Venture Investor
The Column Group -
Venture Investor
SV Life Sciences
